PROphet®
For an informed
therapeutic journey

PROphet®
For an informed
therapeutic journey

PROphet®
For an informed
therapeutic journey

PROphet®
For an informed
therapeutic journey

PROphet is a unique plasma proteomics profiling platform that predicts response to therapy
to guide clinical decision-making related to 1st line immunotherapies

How it works

Pre-treatment simple
blood test collected
at your own home
High throughput
proteomic assay
Bioinformatics and
machine learning
The PROphet report with
response prediction and
decision assistance tool
is sent back to your oncologist
The blood sample is analyzed and processed at
OncoHost’s CLIA* registered lab in Cary, North Carolina
*CLIA number: 34D2250951

The benefits of early foresight

Informed planning
of treatment strategies
Informed, early interventions
and treatment redirection

Currently available for the following indications

Non-Small Cell
Lung Cancer (NSCLC)
Melanoma
(Coming Soon)

Contact us

USA office

1110 SE Cary Parkway, Suite 205
Cary, North Carolina 27518
T. (855) 950-2112
E. support@oncohost-us.com

Israel office

P.O.Box 446, 3 Hamelacha, Binyamina, Israel
T. +972 485 37558
E. info@oncohost.com